by Christopher Freeburn | August 6, 2013 9:59 am
Chinese regulators have asked an American firm to pull two products from the market.
On Tuesday, the General Administration of Quality Supervision, Inspection and Quarantine requested that Abbott Laboratories (ABT) recall two batches infant formula after New Zealand’s embassy warned that some of the formula could contain a harmful bacteria, the Wall Street Journal notes.
The regulator said that formula, which use ingredients from New Zealand’s Fonterra Co-Operative Group, a diary farm, may have been contaminated by Clostridium botulinum, which causes botulism, a potentially debilitating and fatal disease.
Chinese regulators are also recalling a number of other food and beverage products containing potentially contaminated Fonterra ingredients across China.
Last month, Chinese authorities arrested a number of GlaxoSmithKline (GSK) employs for allegedly paying illicit incentives to physicians to prescribe the company’s drugs.
Shares of Abbott Laboratories fell modestly in Tuesday morning trading.
Source URL: https://investorplace.com/2013/08/china-orders-abbott-formula-recall-over-botulism-risk/
Short URL: http://invstplc.com/1fv5BFZ
Copyright ©2018 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.